<code id='8CE1BCDCA0'></code><style id='8CE1BCDCA0'></style>

<acronym id='8CE1BCDCA0'></acronym>

<center id='8CE1BCDCA0'><center id='8CE1BCDCA0'><tfoot id='8CE1BCDCA0'></tfoot></center><abbr id='8CE1BCDCA0'><dir id='8CE1BCDCA0'><tfoot id='8CE1BCDCA0'></tfoot><noframes id='8CE1BCDCA0'>

<optgroup id='8CE1BCDCA0'><strike id='8CE1BCDCA0'><sup id='8CE1BCDCA0'></sup></strike><code id='8CE1BCDCA0'></code></optgroup>

<b id='8CE1BCDCA0'><label id='8CE1BCDCA0'><select id='8CE1BCDCA0'><dt id='8CE1BCDCA0'><span id='8CE1BCDCA0'></span></dt></select></label></b><u id='8CE1BCDCA0'></u>

~~<i id='8CE1BCDCA0'><strike id='8CE1BCDCA0'><tt id='8CE1BCDCA0'><pre id='8CE1BCDCA0'></pre></tt></strike></i>~~

Home» explore» comprehensive

comprehensive

comprehensive

author：fashion 2025-09-12 23:29:34 Page View：62

U.S. President Joe Biden stands with his fingers locked next to an US flag — politics coverage from STAT — President Biden's White House on Monday ballyhooed a routine step in Medicare’s new program to negotiate the prices of prescription drugs.

WASHINGTON — The White House on Monday ballyhooed a routine step in Medicare’s new program to negotiate the prices of prescription drugs, its latest effort to draw attention to the program in an election year.

The news is not controversial: The pharmaceutical companies that make the first ten drugs up for negotiation all submitted counteroffers. It’s an incremental step in the new program, which was created in 2022.

advertisement

Earlier this year, Medicare sent its initial price offers to the companies. Neither the Biden administration nor the drug manufacturers have volunteered any information about the White House’s initial price offers or the counteroffers. The process is scheduled to end by Aug. 1.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Novartis develops a rapidly manufactured CAR
Next article： Bright Health sells Medicare Advantage business to Molina

explore

Hepatitis C has a cure — but many Americans still lack access to it

Hepatitis C has a cure — but many Americans still lack access to it

AdobeIn2005,NickVoyleswasdiagnosedwithhepatitisCafterbeingreleasedfromfiveyearsofincarceration.Anurs

FDA approves first blood sugar monitor without finger pricks

FDA approves first blood sugar monitor without finger pricks

TheFDAhasapprovedadevicefromAbbottthatcontinuouslymonitorsdiabetics’bloodsugarlevelswithoutrequiring

Hepatitis C has a cure — but many Americans still lack access to it

Hepatitis C has a cure — but many Americans still lack access to it

AdobeIn2005,NickVoyleswasdiagnosedwithhepatitisCafterbeingreleasedfromfiveyearsofincarceration.Anurs

Printout prescription drug information shouldn’t go digital

AdobeGettinganewprescriptioncanbeoverwhelming:medicationschedules,foodstoeatoravoid,interactionsbetw

read more